Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

Phase 4

Completed

• Conditions: Skin Cancer
• Interventions: Drug: Discontinuation of Azathioprin

• Registration Number: NCT00492895
• Lead Sponsor: University of Zurich

Brief Summary

Photosensitivity of the skin to UVA and UVB will be determined

Detailed Description

Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months

* Trial with medicinal product

Study Timeline

• Study Start: 2007-06
• Study First Submitted: 2007-06-19
• Study First Submitted QC: 2007-06-26
• Study First Posted: 2007-06-27
• Primary Completion: 2010-12
• Study Completion: 2011-03
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-28
• Last Update Posted: 2013-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
A	Discontinuation of Azathioprin	one arm only. Crossover study

Primary Outcome Measures

Name	Time	Method
Photosensitivity of the skin to UVA and UVB	2 years

Trial Locations

Locations (1)

Clinic for Dermatology, University Hospital of Zurich; 🇨🇭 Zurich, Switzerland